Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
---|
06/12/2008 | WO2008069322A1 Metal coordination compound and light-emitting material using the same |
06/12/2008 | WO2008069242A1 Novel bicyclic heterocyclic compound |
06/12/2008 | US20080139813 Reacting perylene-3,4,9,10-tetracarboxylic acid, a 1,4,5,8-naphthalene-tetracarboxylic acid, or anhydrides, imides, an amine, and a solvent, in the presence of an oxidation/reduction catalyst |
06/12/2008 | US20080139616 Atherosclerosis; inflammatory diseases, Alzheimer's disease, dyslipidemia, metabolic syndrome; 2-isopropyl-5-phenyl-4-[(4-phenylbutyl)amino]isothiazole-3(2H)-thione 1,1-dioxide for example |
06/12/2008 | US20080139585 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian |
06/12/2008 | US20080139556 1-(3-Trifluoromethyl-benzenesulfonyl)-piperidine-2-carboxylic acid [(S)-1-(4-dimethylamino-phenylcarbamoyl)-2-(4-methoxy-phenyl)-ethyl]-amide;FK-binding protein/immunophilins modulator; neurodegenerative diseases; Parkinson's disease, multiple sclerosis, Alzheimer's disease, stroke, spinal cord injury |
06/12/2008 | US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease |
06/12/2008 | US20080139461 Containing the sequence RGD for the preparation of appropriately functionalised antagonists of alpha v beta 3 and alpha v beta 5 integrins; treatment of altered angiogenic phenomena or for the preparation of diagnostically useful compounds |
06/12/2008 | US20080138651 Polyanilines; strong fluorescence and large charge transporting properties |
06/12/2008 | US20080138375 Macrocyclic lactone compounds and methods for their use |
06/12/2008 | US20080138287 3-substituted-2(arylalkyl)-1- azabicycloalkanes and methods of use thereof |
06/12/2008 | DE102006057612A1 New spiro compounds useful as photo-adjustable catalysts in organic synthesis and as photo-catalysts in the polymerization reaction |
06/11/2008 | CN100393704C Novel alkali B of cohosh root and its uses in preparing anti-myocardial ischemia drug |
06/10/2008 | US7384954 3-Imidazol-1-yl-1-azabicyclo[2.2.2]octane; agonist, partial agonist, or antagonist of the alpha 7 nicotinic acetylcholine receptor; antidepressant, anxiolytic agent, cognition activator, neuroprotectant; radiolabel |
06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
06/05/2008 | WO2008066024A1 Anthrapyridone compound, salt thereof, magenta ink composition and colored body |
06/05/2008 | WO2008005295A3 Modulators of muscarinic receptors |
06/05/2008 | US20080132600 Safe toxicity, fire, storage and explosive profile; free radical polymerization; such as n-imidoester derivatives; infrared, ultraviolet, microwave, convection and/or ultrasound curable coatings |
06/05/2008 | US20080132544 Peroxisome Proliferator-Activated Receptor Ligand |
06/05/2008 | US20080132485 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
06/04/2008 | EP1927595A2 Salts of clopidogrel and process for preparation |
06/04/2008 | EP1729723B1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers |
06/04/2008 | CN100391960C Chemical semi-synthetic process for high-purity 10-hydroxy-camptothecin |
06/04/2008 | CN100391958C Chemical compounds |
06/03/2008 | US7381823 Condensing cyclohexanone with cyanoacetamide and reacting 2-cyclohexylidene-2-cyanoacetamide formed with malonate to form 3-cyano-5-carboxy-2,4-dioxo-3-azaspiro[5,5]undecane (claimed as an intermediate); hydrolysis, decarboxylation and further hydrolysis to form 3,3-pentamethyleneglutaramic acid |
05/29/2008 | US20080125429 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents |
05/29/2008 | US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
05/29/2008 | US20080125399 N-[3-(trifluoromethyl)pyridin-2-yl]-4-methyl-6-methyl-3-oxo-4-aza-5 alpha -androst-5-en-17 beta -acetamide; useful for the treatment of conditions caused by androgen deficiency such as osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, cancer cachexia, Alzheimer's disease |
05/29/2008 | US20080122428 Optimized Determination of Voltage Changes Using a Voltage-Sensitive Dye |
05/28/2008 | EP1924559A2 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents |
05/28/2008 | EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
05/28/2008 | CN100390177C Preparation method of 6-cyano-7-methyl-1,1-(2,2-dimethyl-1,3-propylidine dioxy)-5-oxo-1,2,3,5-tetrahydro indolidin (I) |
05/28/2008 | CN100390172C Methane sulfonic acid dolasetron crystallographic form and its preparation method |
05/28/2008 | CN100390146C Process for making risperidone and intermediates therefor |
05/27/2008 | US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
05/27/2008 | US7378427 Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines |
05/22/2008 | WO2008059513A2 Compounds suitable as modulators of hdl |
05/22/2008 | WO2008058342A1 Compounds, compositions and methods for controlling invertebrate pests |
05/22/2008 | US20080119505 (4aR,10bR)-6-(2,6-Dimethoxy-pyridin-3-yl)-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydro-phenanthridine; phosphodiesterase inhibitor; airway obstructions, antiinflammatory agent, antidepressant; dermatoses, eczema, lupus, rheumatoid arthritis, osteoarthritis, AIDS, multiple sclerosis, graft versus host reaction |
05/22/2008 | US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders |
05/22/2008 | US20080119503 Androgen receptor modulators and methods of use thereof |
05/22/2008 | CA2670259A1 Compounds, compositions and methods for controlling invertebrate pests |
05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
05/21/2008 | EP1922381A1 Printable materials |
05/21/2008 | EP1599206A4 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
05/21/2008 | CN101184759A Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
05/20/2008 | US7375225 4-cyanocoumarin derivatives and uses thereof |
05/15/2008 | WO2008056059A2 4-azasterol derivatives, methods for the synthesis thereof and use of same as drugs |
05/15/2008 | WO2008008310A3 Tyrosine kinase inhibitors |
05/15/2008 | US20080114170 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides |
05/14/2008 | EP1919873A1 Fredericamycin derivatives |
05/14/2008 | EP1919867A2 Lisofylline analogues and their pharmeacuetical uses |
05/14/2008 | EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
05/14/2008 | CN101180057A Piperidinyl substituted cyclohexane-1,4-diamines |
05/14/2008 | CN100387598C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
05/14/2008 | CN100387597C Amide substituted imidazopyridines |
05/08/2008 | WO2008052927A1 Heptarylene and octarylene tetracarboxylic acid diimides, and production thereof |
05/08/2008 | WO2007136607A3 Substituted esters as cannabinoid-1 receptor modulators |
05/08/2008 | US20080108647 Treatment of HIV and diseases of immune dysregulation |
05/08/2008 | CA2667826A1 Inhibitors of histone deacetylase |
05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
05/07/2008 | EP1917311A2 Multiple chromophores |
05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
05/06/2008 | US7368457 Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors |
05/01/2008 | US20080103139 3-Carbamoyl-2-Pyridone Derivative |
05/01/2008 | US20080102402 Monomer having sulfonyl group, polymer thereof and photoresist composition including the same |
04/30/2008 | EP1915386A1 Metal complex |
04/30/2008 | CN101171222A Terrylene and quaterrylene derivatives |
04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
04/30/2008 | CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
04/29/2008 | US7365202 Polymorphs of an androgen receptor modulator |
04/29/2008 | US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
04/24/2008 | US20080097122 Synthesis of 1,1-cyclohexane acetic acid monoamide, an intermediate used in the preparation of gabapentin, by hydrolysis reaction of alpha ,--diaminocarbonyl- beta , beta -pentamethylene glutarimide |
04/24/2008 | US20080097100 Opiate Intermediates and Methods of Synthesis |
04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
04/23/2008 | EP1476141B1 Tamper-resistant transdermal opioid delivery devices |
04/23/2008 | EP1333834B1 Antiinflammation agents |
04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
04/23/2008 | CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
04/22/2008 | US7361762 Process for preparing acid salts of Gemifloxacin |
04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
04/17/2008 | WO2008044702A1 Process for production of azabicycloalkanol derivative |
04/17/2008 | WO2008044701A1 Method for producing piperidin-4-one derivative |
04/17/2008 | US20080090865 Non-insulin dependent diabetes; agonists of G-protein coupled receptor 40 (GPR40); for example, 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline |
04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
04/17/2008 | US20080090794 Potassium Channel Inhibitors |
04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
04/15/2008 | US7358362 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis |
04/15/2008 | US7358244 Azabicycloalkane compounds |
04/10/2008 | WO2007019180A3 Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
04/10/2008 | US20080085469 Novel photoacid generators, resist compositions, and patterning process |
04/09/2008 | EP1908752A1 Novel 2-quinolone derivative |
04/09/2008 | EP1907390A2 Diazepinoquinolines, synthesis thereof, and intermediates thereto |
04/09/2008 | CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |